Acute and delayed effects of alprazolam on flight phobics during exposure
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
In order to test if a benzodiazepine would enhance or hinder the therapeutic effects of exposure, immediate and delayed effects of alprazolam on flight phobics were assessed by questionnaires and ambulatory physiological recording. Physiological measures included heart rate, skin conductance level and fluctuations, finger temperature, respiratory sinus arrhythmia, and various respiratory measures derived from two bands calibrated for each subject. Twenty-eight women with flying phobia flew twice at a 1-week interval. One and a half hours before flight 1, 14 randomly assigned phobics received double-blind 1 mg of alprazolam and 14 received placebo. On flight 1, alprazolam reduced self-reported anxiety (5.0 vs 7.4) and symptoms (5.3 vs 3.6) more than placebo, but induced an increase in heart rate (114 vs 105 bpm) and respiratory rate (22.7 vs 18.3 breaths/min). Before flight 2, the alprazolam group did not expect to be more anxious than the placebo group (6.7 vs 6.5), but in fact indicated more anxiety during flight (8.5 vs 5.6), and a substantial increase in panic attacks from flight 1 to flight 2 (7% vs 71%). Heart rates in the alprazolam group increased further (123 bpm). Results indicate that alprazolam increases physiological activation under acute stress conditions and hinders therapeutic effects of exposure in flying phobia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emotional processing of fear: Exposure to corrective information.
Foa, E. B., & Kozak, M. J. (1986) · Psychological Bulletin · doi:10.1037/0033-2909.99.1.20 · Cited by 5,396
Clark, D. M. (1986) · Behaviour Research and Therapy · doi:10.1016/0005-7967(86)90011-2 · Cited by 2,422 · cited 1×
“Eine derartige Erklärung steht im Einklang mit einer kognitiven Konzeptualisierung von Panikanfällen [Clark, 1986; Margraf et al., 1986].”
BackgroundGender and age differences in the prevalence of specific fears and phobias
Fredrikson, M., Annas, P., Fischer, H., & Wik, G. (1996) · Behaviour Research and Therapy · doi:10.1016/0005-7967(95)00048-3 · Cited by 548 · cited 1×
“[Fredrikson et al., 1996].”
Grossman, P., Karemaker, J., & Wieling, W. (1991) · Psychophysiology · doi:10.1111/j.1469-8986.1991.tb00412.x · Cited by 471 · cited 1×
“Rüschlüsse von noninvasiven Messungen der RSA auf die Vaguskontrolle der Herzfrequenz müssen jedoch mit Vorsicht interpretiert werden, wenn die Gruppen sich in der Atemfrequenz unterscheiden, da eine erhöhte Atemfrequenz zu einer Unterschätzung der Vaguskontrolle führt [Grossman et al., 1991].”
BackgroundEndocrine and cardiovascular responses during phobic anxiety.
Nesse, R. M., Curtis, G. C., Thyer, B. A., McCann, D. S., Huber-Smith, M. J., & Knopf, R. F. (1985) · Psychosomatic Medicine · doi:10.1097/00006842-198507000-00002 · Cited by 173 · cited 1×
“Er wurde untermauert durch Veränderungen der Herzfrequenz, ein Standardmaß für physiologische Angstaktivierung, das erwiesenermaßen gut zwischen ängstlichen und nichtängstlichen Personen unterscheidet [Nesse et al., 1985; Sartory et al., 1992].”
BackgroundDoes Cognitive Behavior Therapy Assist Slow-Taper Alprazolam Discontinuation in Panic Disorder?
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.876 · Cited by 153 · cited 1×
“Diese Vorgehensweise hat sich bei der Behandlung der Panikstörung als effektiv für die Rückfallprävention erwiesen [Ballenger et al., 1993; Spiegel et al., 1994].”
BackgroundBeckham, J. C., Vrana, S. R., May, J. G., Gustafson, D. J., & Smith, G. R. (1990) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(90)90002-3 · Cited by 86
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Treatment of specific phobia in adults
Choy, Y., Fyer, A. J., & Lipsitz, J. D. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.10.002 · Cited by 571
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
“…[e.g. benzodiazepines (BZD)] showed that the combination was no more effective [in some instances even counterproductive (Marks et al., 1993; Wilhelm & Roth, 1997)] than psycho- or pharmacotherapy alone [for details see (Dunlop et al., 2012; Hofmann, 2012; Otto et al., 2010a,b; Rodrigues…”
BackgroundWilhelm, F. H., & Grossman, P. (2010) · Biological Psychology · doi:10.1016/j.biopsycho.2010.01.017 · Cited by 307
Self-citationBenzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives
Guina, J., & Merrill, B. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020017 · Cited by 253
Metadata
- Authors
- Wilhelm, F. H., & Roth, W. T.
- Venue
- Behaviour Research and Therapy
- Publisher
- Elsevier BV
- Published
- 1997-09
- Volume
- 35
- Issue
- 9
- Pages
- 831-841
- ISSN
- 0005-7967 (ISSN-L)
- OpenAlex
- W2062727210
- Cited by
- 82
- References
- 7
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute and delayed effects of alprazolam on flight phobics during exposure. https://app.cochat.ai/papers/10.1016/s0005-7967(97)00033-8
- The paper
- Wilhelm, F. H., & Roth, W. T. (1997). Acute and delayed effects of alprazolam on flight phobics during exposure. Behaviour Research and Therapy. https://doi.org/10.1016/s0005-7967(97)00033-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.